ALNY
Price
$321.94
Change
-$3.06 (-0.94%)
Updated
Jun 25 closing price
Capitalization
41.98B
35 days until earnings call
IONS
Price
$40.00
Change
+$0.36 (+0.91%)
Updated
Jun 25 closing price
Capitalization
6.37B
35 days until earnings call
Interact to see
Advertisement

ALNY vs IONS

Header iconALNY vs IONS Comparison
Open Charts ALNY vs IONSBanner chart's image
Alnylam Pharmaceuticals
Price$321.94
Change-$3.06 (-0.94%)
Volume$632.57K
Capitalization41.98B
Ionis Pharmaceuticals
Price$40.00
Change+$0.36 (+0.91%)
Volume$1.99M
Capitalization6.37B
ALNY vs IONS Comparison Chart in %
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. IONS commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a StrongBuy and IONS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ALNY: $321.94 vs. IONS: $40.00)
Brand notoriety: ALNY and IONS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 70% vs. IONS: 127%
Market capitalization -- ALNY: $41.98B vs. IONS: $6.37B
ALNY [@Biotechnology] is valued at $41.98B. IONS’s [@Biotechnology] market capitalization is $6.37B. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileIONS’s FA Score has 0 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • IONS’s FA Score: 0 green, 5 red.
According to our system of comparison, ALNY is a better buy in the long-term than IONS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while IONS’s TA Score has 4 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 4 bearish.
  • IONS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ALNY and IONS are a good buy in the short-term.

Price Growth

ALNY (@Biotechnology) experienced а +3.08% price change this week, while IONS (@Biotechnology) price change was +8.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +31.79%, and the average quarterly price growth was +15.79%.

Reported Earning Dates

ALNY is expected to report earnings on Jul 31, 2025.

IONS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($42B) has a higher market cap than IONS($6.37B). ALNY YTD gains are higher at: 36.815 vs. IONS (14.416). ALNY has higher annual earnings (EBITDA): -152.58M vs. IONS (-357.21M). ALNY has more cash in the bank: 2.63B vs. IONS (2.15B). ALNY has less debt than IONS: ALNY (1.3B) vs IONS (1.41B). ALNY has higher revenues than IONS: ALNY (2.35B) vs IONS (717M).
ALNYIONSALNY / IONS
Capitalization42B6.37B660%
EBITDA-152.58M-357.21M43%
Gain YTD36.81514.416255%
P/E RatioN/AN/A-
Revenue2.35B717M327%
Total Cash2.63B2.15B123%
Total Debt1.3B1.41B92%
FUNDAMENTALS RATINGS
ALNY vs IONS: Fundamental Ratings
ALNY
IONS
OUTLOOK RATING
1..100
1821
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
96
Overvalued
PROFIT vs RISK RATING
1..100
20100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
4042
P/E GROWTH RATING
1..100
10066
SEASONALITY SCORE
1..100
9537

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IONS's Valuation (96) in the Biotechnology industry is in the same range as ALNY (99). This means that IONS’s stock grew similarly to ALNY’s over the last 12 months.

ALNY's Profit vs Risk Rating (20) in the Biotechnology industry is significantly better than the same rating for IONS (100). This means that ALNY’s stock grew significantly faster than IONS’s over the last 12 months.

IONS's SMR Rating (98) in the Biotechnology industry is in the same range as ALNY (100). This means that IONS’s stock grew similarly to ALNY’s over the last 12 months.

ALNY's Price Growth Rating (40) in the Biotechnology industry is in the same range as IONS (42). This means that ALNY’s stock grew similarly to IONS’s over the last 12 months.

IONS's P/E Growth Rating (66) in the Biotechnology industry is somewhat better than the same rating for ALNY (100). This means that IONS’s stock grew somewhat faster than ALNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALNYIONS
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
72%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
70%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 1 day ago
62%
Declines
ODDS (%)
Bearish Trend 16 days ago
66%
Bearish Trend 11 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTCR0.550.01
+1.89%
Heartcore Enterprises
DB29.28-0.03
-0.10%
Deutsche Bank Aktiengesellschaft
LPL3.55-0.02
-0.56%
LG Display Co Ltd
NCDL16.30-0.11
-0.67%
Nuveen Churchill Direct Lending Corp
QSG9.34-0.71
-7.06%
QuantaSing Group Limited

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
-0.94%
IONS - ALNY
53%
Loosely correlated
+0.91%
ARGX - ALNY
47%
Loosely correlated
-1.33%
SGMO - ALNY
42%
Loosely correlated
+13.27%
VXRT - ALNY
40%
Loosely correlated
-3.93%
ALLO - ALNY
37%
Loosely correlated
-0.80%
More

IONS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IONS has been loosely correlated with ALNY. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IONS jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IONS
1D Price
Change %
IONS100%
+0.91%
ALNY - IONS
54%
Loosely correlated
-0.94%
IDYA - IONS
50%
Loosely correlated
+1.06%
ROIV - IONS
48%
Loosely correlated
-1.21%
BEAM - IONS
48%
Loosely correlated
-2.27%
XENE - IONS
47%
Loosely correlated
-1.27%
More